What is the official website of IntrinsiQ Specialty Solutions ?

The official website of IntrinsiQ Specialty Solutions is http://www.intrinsiq.com.

What is IntrinsiQ Specialty Solutions's cybersecurity risk score?

IntrinsiQ Specialty Solutions has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has IntrinsiQ Specialty Solutions experienced?

According to Rankiteo, IntrinsiQ Specialty Solutions currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has IntrinsiQ Specialty Solutions been affected by any supply chain cyber incidents ?

According to Rankiteo, IntrinsiQ Specialty Solutions has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does IntrinsiQ Specialty Solutions have SOC 2 Type 1 certification ?

According to Rankiteo, IntrinsiQ Specialty Solutions is not certified under SOC 2 Type 1.

Does IntrinsiQ Specialty Solutions have SOC 2 Type 2 certification ?

According to Rankiteo, IntrinsiQ Specialty Solutions does not hold a SOC 2 Type 2 certification.

Does IntrinsiQ Specialty Solutions comply with GDPR ?

According to Rankiteo, IntrinsiQ Specialty Solutions is not listed as GDPR compliant.

Does IntrinsiQ Specialty Solutions have PCI DSS certification ?

According to Rankiteo, IntrinsiQ Specialty Solutions does not currently maintain PCI DSS compliance.

Does IntrinsiQ Specialty Solutions comply with HIPAA ?

According to Rankiteo, IntrinsiQ Specialty Solutions is not compliant with HIPAA regulations.

Does IntrinsiQ Specialty Solutions have ISO 27001 certification ?

According to Rankiteo,IntrinsiQ Specialty Solutions is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does IntrinsiQ Specialty Solutions operate in ?

IntrinsiQ Specialty Solutions operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does IntrinsiQ Specialty Solutions have ?

IntrinsiQ Specialty Solutions employs approximately 92 people worldwide.

Does IntrinsiQ Specialty Solutions own any subsidiaries ?

IntrinsiQ Specialty Solutions presently has no subsidiaries across any sectors.

How many LinkedIn followers does IntrinsiQ Specialty Solutions have ?

IntrinsiQ Specialty Solutions's official LinkedIn profile has approximately 2,353 followers.

What is the NAICS classification code for IntrinsiQ Specialty Solutions ?

IntrinsiQ Specialty Solutions is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does IntrinsiQ Specialty Solutions have a Crunchbase profile ?

No, IntrinsiQ Specialty Solutions does not have a profile on Crunchbase.

Does IntrinsiQ Specialty Solutions have a LinkedIn profile ?

Yes, IntrinsiQ Specialty Solutions maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/intrinsiq-llc.

How many cybersecurity incidents has IntrinsiQ Specialty Solutions experienced ?

As of June 25, 2026, Rankiteo reports that IntrinsiQ Specialty Solutions has experienced 11 cybersecurity incidents.

How many peer or competitor companies does IntrinsiQ Specialty Solutions have ?

IntrinsiQ Specialty Solutions has an estimated 5,696 peer or competitor companies worldwide.

What types of cybersecurity incidents has IntrinsiQ Specialty Solutions faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ISS

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

IntrinsiQ Specialty Solutions Vendor Cyber Rating & Cyber Score

intrinsiq.com

Add Your Compliance Badge

IntrinsiQ Specialty Solutions, a part of Cencora, is the leading provider of electronic health records, practice financial management solutions, and pharmaceutical analytics in the independent physician specialty market. They provide software solutions to over 6,000 specialty physicians across the United States and provide analytic solutions to life sciences companies within the specialty drug market. For analytics solutions for life sciences, visit intrinsiqanalytics.com. For software solutions, services or clinical and business intelligence for providers visit intrinsiq.com. IntrinsiQ Specialty Solutions is part of the Cencora family of companies. Cencora, previously known as AmerisourceBergen, is a leading global pharmaceutical

ISS A.I CyberSecurity Scoring

Scoring History

ISS

IntrinsiQ Specialty Solutions CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

IntrinsiQ Specialty...

Breach

100

9/2025

AME476204709202...

Cencora

Breach

100

1/2025

INOCEN177580230...

IntrinsiQ Specialty...

Breach

11/2024

WOR100072725

IntrinsiQ Specialty...

Breach

100

9/2024

MWI630072625

IntrinsiQ Specialty...

Breach

8/2024

AME345072925

IntrinsiQ Specialty...

Breach

4/2024

AME425072825

IntrinsiQ Specialty...

Breach

2/2024

MWI122072925

IntrinsiQ Specialty...

Breach

2/2024

AME453224509302...

IntrinsiQ Specialty...

Breach

2/2024

CEN270212709302...

IntrinsiQ Specialty...

Cyber Attack

03/2023

ALL363723

IntrinsiQ Specialty...

Breach

02/2023

AME62016223

Loading…

A.I.

ISS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ISS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for IntrinsiQ Specialty Solutions in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for IntrinsiQ Specialty Solutions in 2026.

Incident Types ISS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for IntrinsiQ Specialty Solutions in 2026.

Incident History - ISS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

IntrinsiQ Specialty Solutions Subsidiaries

ISS

Pharmaceutical Manufacturing

Website: http://www.intrinsiq.com

Company Size: 92

CencoraHospitals and Health Care

AmerisourceBergenHospitals and Health Care

Innomar StrategiesPharmaceutical Manufacturing

American Health PackagingPharmaceutical Manufacturing

MWI Animal HealthVeterinary Services

ION Oncology Practice NetworkPharmaceutical Manufacturing

ASD HealthcarePharmaceutical Manufacturing

ICSPharmaceutical Manufacturing

US BioservicesPharmaceutical Manufacturing

Besse MedicalPharmaceutical Manufacturing

Alliance HealthcarePharmaceutical Manufacturing

World CourierTransportation, Logistics, Supply Chain and Storage

Triose, Inc.Transportation, Logistics, Supply Chain and Storage

Loading…

IntrinsiQ Specialty Solutions Similar Companies

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Loading…

NEWS

IntrinsiQ Specialty Solutions CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 16, 2025 07:00 AM

Oncology biomarker data fuels precision care — IntrinsiQ expands insights across oncology, retina, specialty

IntrinsiQ (Cencora) adds oncology biomarker data plus expanded retina and therapeutic-area insights to enable precision medicine,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-56785

SUMMARY

FlatPress versions prior to commit 10be83c, contains a stored cross-site scripting vulnerability in comment and contact forms where name, URL, and email fields are rendered without proper output encoding in Smarty templates. Attackers can inject arbitrary HTML and JavaScript through these fields to execute malicious scripts in browsers of viewers including administrators, or bypass URL scheme validation to inject javascript: or data: URIs.

Published

Date2026-06-23

Updated

Date2026-06-23

RISK INFORMATION (Score: 8.2)

cvss3

Base Score: 8.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N

cvss4

Base Score: 8.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

2.8

REFERENCES

CVE-2026-54588

SUMMARY

Poweradmin is a web-based DNS administration tool for PowerDNS server. Versions prior to 4.2.4 and 4.3.3 use the attacker-controlled `HTTP_HOST` request header as the authoritative source for building callback URLs in its OIDC, SAML, and logout authentication flows without any validation. An unauthenticated attacker can poison the `redirect_uri` sent to the Identity Provider, causing the IdP to redirect the victim's authorization code to an attacker-controlled server - resulting in full account takeover with no credentials required. Versions 4.2.4 and 4.3.3 patch the issue.

Published

Date2026-06-23

Updated

Date2026-06-23

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:L

Impact Score

Exploitability

2.8

REFERENCES

CVE-2026-48493

SUMMARY

Snipe-IT is an IT asset/license management system. In versions prior to 8.6.0, a user with only users.edit can send a PATCH to /api/v1/users/{their_own_id} and grant themselves any permission except admin and superuser — for example `assets.view`, `assets.create`, `reports.view`, import, etc. The issue is patched in version 8.6.0.

Published

Date2026-06-23

Updated

Date2026-06-23

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:H/A:N

Impact Score

4.2

Exploitability

1.2

REFERENCES

CVE-2026-47693

SUMMARY

Poweradmin is a web-based DNS administration tool for PowerDNS server. Versions prior to 4.2.4 and 4.3.3 are vulnerable to CSV Injection (Formula Injection) in its log export functionality. User-controlled data — specifically the username field — is written to exported CSV files without sanitizing formula trigger characters (=, +, -, @). When an administrator exports activity logs and opens the resulting CSV in a spreadsheet application (Microsoft Excel, LibreOffice Calc, Google Sheets), any formula stored in a username is executed by the application. This can be used for phishing attacks against administrators or data exfiltration. Versions 4.2.4 and 4.3.3 patch the issue.

Published

Date2026-06-23

Updated

Date2026-06-23

RISK INFORMATION (Score: 6.9)

cvss3

Base Score: 6.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:H/I:L/A:N

Impact Score

4.7

Exploitability

1.7

REFERENCES

CVE-2026-12164

SUMMARY

Fortra File Integrity Monitoring (FIM), formerly Tripwire Enterprise, versions prior to 9.4.0 may assign incorrect or elevated effective permissions to users created by the tetool import command while FIM is running, particularly when the import also creates or changes roles or role-permission relationships.

Published

Date2026-06-23

Updated

Date2026-06-23

RISK INFORMATION (Score: 4.4)

cvss3

Base Score: 4.4

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N

Impact Score

3.6

Exploitability

0.8

REFERENCES

https://www.fortra.com/security/advisories/product-security/fi-2026-010

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…